Foundation / Corporation
Canadian Cancer Society (CCS)
01/15/19 5:00 PM Eastern
Grants to Canada researchers to support innovative, creative problem solving in cancer research. Funding is intended to support unconventional concepts, approaches or methodologies to address problems in cancer research, particularly breast cancer research. Of particular interest are applications focused on cancer prevention and survivorship.
Innovation grants have been created to support the highest quality creative problem solving in cancer research. The goal of this CCS grant program is to support the development and testing of unconventional concepts and approaches to address problems in cancer research, enhance understanding of cancer, and generate new approaches to confront the challenges faced in defeating cancer. Successful projects may be based on “high risk” ideas that have a strong potential for high reward. With strong emphasis on innovation, the program encourages bold attempts to test novel hypotheses and/or generate new knowledge and/or improvements related to cancer prevention, detection, diagnosis, treatment, and support.
It is hoped that this grant program will accelerate the introduction of innovation into the entire cancer research system and contribute to the scientific idea pipeline. Proposals with scientific merit that are deemed derivative, pursue next logical steps, or seek to make incremental advancements are not considered innovative. Significant findings from investigators funded by innovation grants may be developed further through CCS Research “Innovation to Impact” and “Impact” Grants or operating grants offered by other agencies.
The review criteria will include, but not necessarily be restricted to, five assessment categories: Innovation, Research Strategy, Investigator(s), Environment, and Cancer Relevance.
Innovation:
- Potential to address an important problem or a critical barrier to progress in the field
- Potential to improve or apply a new theoretical concept, approach, methodology or tool
- Degree to which the research is original, unique and creative
- Potential gain relative to (any) perceived risk
- Degree to which the research proposes new paradigms or challenges existing ones
Research Strategy:
- Scientific merit and convincing rationale that considers critical review and analysis of preliminary data and/or published literature, as appropriate
- Identification of potential problems and how they will be addressed, including alternative approaches
- Appropriateness of the term and amount of support requested
Investigator(s):
- Qualifications and appropriate expertise of the investigator(s)
Environment:
- Quality of the research environment in which the work will take place
Cancer relevance
- Potential impact on cancer control
- Degree to which the proposed research addresses CCS’s mission to eradicate cancer and enhance the quality of life for people living with and beyond cancer.
Awards will be granted for the purchase and maintenance of animals, expendable supplies, minor items of equipment, payment of graduate students, postdoctoral fellows and technical and professional assistants, open access publication costs, research travel and permanent equipment.
Funding will be provided to support the direct costs of research, including supplies, salaries, and equipment associated with the proposed work. Equipment requests cannot exceed 25% of the requested budget.
Grantees may use up to 5% of the grant budget for legitimate scientific and conference travel.
GrantWatch ID#: 164034
22
Grant budgets may be up to $100,000 per year to a maximum of $200,000 per grant.
Grant expenditures may be extended over 3 years if justified in the application. Grants will be non-renewable.
An applicant must hold a firm academic position (as a primary appointment) which allows the individual to engage in independent research activities for the duration of the project and includes the ability to supervise trainees and publish research results.
A researcher designated as the Principal Investigator must be based in, or formally affiliated with, an eligible Canadian Host Institution such as a university, research institute or health care agency. Graduate students, postdoctoral fellows, research associates, Adjunct Professors or Status only appointments (except where they hold a firm academic position at another Canadian institution), technical support staff, or investigators based outside of Canada are not eligible to be a Principal Investigator. Both the Principal Investigator and executive authorities of the Host Institution are required to agree to the terms of the Host Institution/Canadian Cancer Society Agreement included as part of the application, thereby acknowledging and agreeing to all the responsibilities and obligations outlined in that Agreement.
The person named as the PI remains the PI on a grant for the duration of the grant unless given express permission by the Canadian Cancer Society.
Applicants who do not yet hold an eligible position:
Investigators who have a firm offer of an academic position (as defined above) at an eligible Host Institution and where the appointment is not contingent on the success of a pending application, can submit an application as Principal Investigator provided that the position commences by the start date of the grant. In such cases, a letter from an appropriate authority of the Host Institution must be included, which provides clear details as to the exact nature of the appointment (including title and major responsibilities), as well as the expected start date and duration of the appointment.
A researcher designated as Co-Principal Investigator or Co-applicant is a researcher who may or may not have a formal affiliation with the Host Institution, but will take responsibility for particular administrative and scientific aspects of the research project. These categories can include Adjunct Professors or Status only appointments. These categories may not include graduate students, postdoctoral fellows, research associates, technical support staff, or investigators based outside of Canada. These individuals are not eligible to receive salary support from a grant.
The third category, Additional Authors, formally recognizes other individuals who will make substantial intellectual contributions to the research project or have contributed to the drafting of the application itself, but who are not eligible to be included as Co-Principal Investigators or Co-applicants. Students, postdoctoral fellows, research associates lay contributors and investigators based outside of Canada may be included in this category. Students, post-doctoral fellows and research associates may receive salary support from a grant.
Any question of eligibility or unusual circumstances not described above will be reviewed and an assessment by CCS will be made.
A maximum of one application per Principal Investigator or Co-Principal Investigator will be permitted in each competition.
These grants do not provide for personal salary support of the Principal Investigator (PI) and/or Co-applicants nor for institutional overhead costs.
Indirect costs are not eligible.
Deadline Dates:
- Full application due date: January 15, 2019 by 5:00 PM Eastern
- Results announcement: July, 2019
- Anticipated start date: August 1, 2019
Please be advised that no funds will be released to successful applicants until all required certificates are received.
Eligibility and Requirements:
http://www.cancer.ca/en/research/policies-and-administration/administration/eligibility-and-requirements/
Documentation for Applicants:
http://www.cancer.ca/en/research/grants-and-awards/applications/user-documentation/documentation-for-applicants/
How to Apply Online:
http://www.cancer.ca/en/research/grants-and-awards/applications/how-to-apply-online/
Video Tutorials for Online Application System:
http://www.cancer.ca/en/research/grants-and-awards/applications/video-tutorials-for-online-application-system/
Before starting your grant application, please review the funding source's website listed below for updates/changes/addendums/conferences/LOIs.
Register and Apply online:
https://applyforfunds.cancer.ca/egrams_ccs/user/home.aspx
Lori Moser
research@cancer.ca
(416) 934-5310
Canadian Cancer Society Research Institute
55 St. Clair Avenue W., Suite 300
Toronto, Ontario M4V 2Y7
Canada: Alberta British Columbia Manitoba New Brunswick Newfoundland and Labrador Northwest Territories Nova Scotia Nunavut Ontario Prince Edward Island Quebec Saskatchewan Yukon
One moment please...
Phone: